Status:
UNKNOWN
The Clinical Effects of Modified TRS Treatment
Lead Sponsor:
Eye & ENT Hospital of Fudan University
Conditions:
Tinnitus, Subjective
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Objective Tinnitus is one of the most common acoustic disorders by affecting 5-43% people around the world, and tinnitus is harmful to social and individuals, inducing to annoyance, irritability, anxi...
Eligibility Criteria
Inclusion
- Adults aged between 18 to 80 years old;
- Diagnosed with subjective tinnitus;
- Chronic tinnitus: tinnitus course ≥3 months;
- Be able to understand and communicate with Mandarin；
- The average pure tone threshold (0.5, 1, 2kHz) ≤ 55dB HL of the worse ear;
- Subjects are able to understand the purpose of the study, volunteer to participate and cooperate with the instructors to complete the experiment, and be willing to sign the informed consent.
Exclusion
- Pulsatile tinnitus and objective tinnitus；
- Having significant health issues that affect or prevent participation or continue with the follow-up;
- Diseases requiring other medical intervention first (eg, infections, tumors, otosclerosis, Meniere's disease, the acute stage of sudden sensorineural hearing loss);
- People with severe hyperacusis, severe anxiety, depression and other psychiatric disorders；
- Currently participating in other research projects that may affect tinnitus；
- Subjects who are not considered suitable for this clinical trial by the researchers.
Key Trial Info
Start Date :
August 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2022
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT04026932
Start Date
August 1 2019
End Date
February 1 2022
Last Update
July 19 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Otorhinolaryngology Department of Affiliated Eye and ENT Hospital, Fudan University, Shanghai, China
Shanghai, Shanghai Municipality, China, 200031